Pathophysiology during neural information processing in ADHD

Klinik für Psychiatrie und Psychotherapie der Uniklinik Köln0 个研究点目标入组 32 人开始时间: 2018年7月18日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Amendment 1+2:
•1) Age 18-45
•2) Sufficient understanding of the German language for the questionnaire survey
•3) Written informed consent of patients
•4) Diagnosis of ADHD according to ICD-10
•5) Clinically indicated treatment with methylphenidate
•6) Stable psychotropic medication (except ADHD medication) for at least 4 weeks
•Amendment 1:
•unmedicated, concerning methylphenidate
•Amendment 2:
•Medicated for at least 6 months with methylphenidate

•1. known neurological disorders affecting the brain, including condition after craniocerebral trauma with unconsciousness greater than 5 minutes
•2. harmful substance use according to ICD-10
•3. taking antipsychotics up to 4 weeks before baseline and during the examination period
•For Amendment 1:
•4. taking pharmaceuticals for ADHD treatment on the day of the examination (not extended release) or within 48 hours (extended release and atomoxetine) before baseline
•For Amendment 2:
•4. taking pharmaceuticals for ADHD treatment on the day of the examination (not extemded release) or within 48 hours (extended release and atomoxetine) before baseline, with the exception of methylphenidate
•5. motor hyperactivity at the time of measurement that makes an EEG examination impossible
•6. known IQ < 70
•7. premature birth < 32 wks

发起方

Klinik für Psychiatrie und Psychotherapie der Uniklinik Köln